Elevance Health PE Ratio 2010-2024 | ELV
Current and historical p/e ratio for Elevance Health (ELV) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Elevance Health PE ratio as of December 26, 2024 is 10.75.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Elevance Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-12-26 | 373.66 | 13.62 | |
| 2024-09-30 | 517.85 | $27.43 | 18.88 |
| 2024-06-30 | 538.01 | $28.52 | 18.86 |
| 2024-03-31 | 513.30 | $26.46 | 19.40 |
| 2023-12-31 | 465.28 | $25.17 | 18.49 |
| 2023-09-30 | 428.31 | $25.47 | 16.82 |
| 2023-06-30 | 435.60 | $26.70 | 16.31 |
| 2023-03-31 | 449.39 | $25.70 | 17.49 |
| 2022-12-31 | 499.74 | $24.79 | 20.16 |
| 2022-09-30 | 441.44 | $25.49 | 17.32 |
| 2022-06-30 | 467.76 | $24.94 | 18.76 |
| 2022-03-31 | 474.88 | $25.40 | 18.70 |
| 2021-12-31 | 446.90 | $24.72 | 18.08 |
| 2021-09-30 | 358.40 | $22.28 | 16.09 |
| 2021-06-30 | 365.94 | $17.02 | 21.50 |
| 2021-03-31 | 343.03 | $18.68 | 18.36 |
| 2020-12-31 | 305.82 | $17.91 | 17.08 |
| 2020-09-30 | 255.07 | $19.34 | 13.19 |
| 2020-06-30 | 248.85 | $23.02 | 10.81 |
| 2020-03-31 | 214.15 | $18.47 | 11.59 |
| 2019-12-31 | 283.88 | $18.44 | 15.39 |
| 2019-09-30 | 225.04 | $16.43 | 13.70 |
| 2019-06-30 | 263.67 | $15.50 | 17.01 |
| 2019-03-31 | 267.36 | $15.12 | 17.68 |
| 2018-12-31 | 244.03 | $14.20 | 17.19 |
| 2018-09-30 | 254.64 | $17.26 | 14.75 |
| 2018-06-30 | 220.56 | $16.44 | 13.42 |
| 2018-03-31 | 202.92 | $15.62 | 12.99 |
| 2017-12-31 | 207.14 | $14.36 | 14.42 |
| 2017-09-30 | 174.26 | $11.06 | 15.76 |
| 2017-06-30 | 172.03 | $10.56 | 16.29 |
| 2017-03-31 | 150.70 | $10.31 | 14.62 |
| 2016-12-31 | 130.50 | $9.21 | 14.17 |
| 2016-09-30 | 113.24 | $8.52 | 13.29 |
| 2016-06-30 | 118.08 | $8.65 | 13.65 |
| 2016-03-31 | 124.35 | $8.87 | 14.02 |
| 2015-12-31 | 124.14 | $9.33 | 13.31 |
| 2015-09-30 | 124.06 | $10.45 | 11.87 |
| 2015-06-30 | 144.83 | $10.24 | 14.14 |
| 2015-03-31 | 135.72 | $9.67 | 14.04 |
| 2014-12-31 | 109.99 | $8.98 | 12.25 |
| 2014-09-30 | 104.34 | $7.67 | 13.60 |
| 2014-06-30 | 93.52 | $7.61 | 12.29 |
| 2014-03-31 | 86.16 | $7.69 | 11.20 |
| 2013-12-31 | 79.58 | $8.18 | 9.73 |
| 2013-09-30 | 71.72 | $9.20 | 7.80 |
| 2013-06-30 | 69.90 | $9.19 | 7.61 |
| 2013-03-31 | 56.29 | $8.49 | 6.63 |
| 2012-12-31 | 51.47 | $8.13 | 6.33 |
| 2012-09-30 | 48.76 | $7.58 | 6.43 |
| 2012-06-30 | 53.36 | $7.33 | 7.28 |
| 2012-03-31 | 61.47 | $7.28 | 8.44 |
| 2011-12-31 | 54.94 | $7.19 | 7.64 |
| 2011-09-30 | 53.93 | $7.63 | 7.07 |
| 2011-06-30 | 64.83 | $7.57 | 8.56 |
| 2011-03-31 | 57.25 | $7.39 | 7.75 |
| 2010-12-31 | 46.47 | $6.91 | 6.73 |
| 2010-09-30 | 46.29 | $11.46 | 4.04 |
| 2010-06-30 | 39.99 | $11.15 | 3.59 |
| 2010-03-31 | 52.62 | $10.87 | 4.84 |
| 2009-12-31 | 47.64 | $10.07 | 4.73 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $86.660B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $43.795B | 16.47 |
| DiDi Global (DIDIY) | China | $22.310B | 0.00 |
| Natera (NTRA) | United States | $21.076B | 0.00 |
| ICON (ICLR) | Ireland | $17.639B | 15.71 |
| Viatris (VTRS) | United States | $14.992B | 4.62 |
| Avantor (AVTR) | United States | $14.620B | 21.92 |
| Revvity (RVTY) | United States | $13.691B | 23.78 |
| BioMerieux (BMXMF) | France | $12.233B | 0.00 |
| CochLear (CHEOY) | Australia | $12.042B | 0.00 |
| Solventum (SOLV) | United States | $11.564B | 0.00 |
| Doximity (DOCS) | United States | $10.907B | 64.20 |
| Medpace Holdings (MEDP) | United States | $10.659B | 30.03 |
| Charles River Laboratories (CRL) | United States | $9.545B | 18.44 |
| HealthEquity (HQY) | United States | $8.442B | 42.35 |
| Sonic Healthcare (SKHHY) | Australia | $8.258B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.388B | 29.74 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $3.850B | 3.88 |
| Sotera Health (SHC) | United States | $3.827B | 20.47 |
| BrightSpring Health Services (BTSG) | United States | $3.065B | 65.18 |
| Surgery Partners (SGRY) | United States | $2.716B | 30.97 |
| Concentras Parent (CON) | United States | $2.623B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.382B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.183B | 0.00 |
| Premier (PINC) | United States | $2.090B | 10.88 |
| Alignment Healthcare (ALHC) | United States | $2.078B | 0.00 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.723B | 45.20 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.641B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.295B | 0.00 | |
| Progyny (PGNY) | United States | $1.253B | 25.36 |
| Embecta (EMBC) | United States | $1.211B | 8.47 |
| Pediatrix Medical (MD) | United States | $1.173B | 11.48 |
| CareDx (CDNA) | United States | $1.150B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.918B | 6.21 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.779B | 0.00 |
| SBC Medicals (SBC) | United States | $0.604B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.549B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.496B | 0.00 |
| DocGo (DCGO) | United States | $0.447B | 16.85 |
| Sonida Senior Living (SNDA) | United States | $0.442B | 0.00 |
| Enhabit (EHAB) | United States | $0.389B | 33.61 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.283B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.274B | 0.00 |
| LifeMD (LFMD) | United States | $0.230B | 0.00 |
| Biodesix (BDSX) | United States | $0.212B | 0.00 |
| MultiPlan (MPLN) | United States | $0.203B | 0.00 |
| Beauty Health (SKIN) | United States | $0.195B | 0.00 |
| Nutex Health (NUTX) | United States | $0.179B | 0.00 |
| ModivCare (MODV) | United States | $0.157B | 8.53 |
| So-Young (SY) | China | $0.099B | 16.74 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 1.59 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.036B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |